Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination
Top Cited Papers
- 7 September 2003
- journal article
- research article
- Published by Springer Nature in Nature Immunology
- Vol. 4 (10), 1023-1028
- https://doi.org/10.1038/ni974
Abstract
Activation-induced cytidine deaminase (AID) is a 'master molecule' in immunoglobulin (Ig) class-switch recombination (CSR) and somatic hypermutation (SHM) generation, AID deficiencies are associated with hyper-IgM phenotypes in humans and mice. We show here that recessive mutations of the gene encoding uracil–DNA glycosylase (UNG) are associated with profound impairment in CSR at a DNA precleavage step and with a partial disturbance of the SHM pattern in three patients with hyper-IgM syndrome. Together with the finding that nuclear UNG expression was induced in activated B cells, these data support a model of CSR and SHM in which AID deaminates cytosine into uracil in targeted DNA (immunoglobulin switch or variable regions), followed by uracil removal by UNG.Keywords
This publication has 45 references indexed in Scilit:
- RNA AIDs DNANature Immunology, 2003
- The influence of transcriptional orientation on endogenous switch region functionNature Immunology, 2003
- R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cellsNature Immunology, 2003
- Early-Onset Brain Tumor and Lymphoma in MSH2-Deficient ChildrenAmerican Journal of Human Genetics, 2003
- Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generationBiochemical Society Transactions, 2002
- DNA Double-Strand BreaksThe Journal of Experimental Medicine, 2002
- Molecular Mechanism of Class Switch Recombination: Linkage with Somatic HypermutationAnnual Review of Immunology, 2002
- AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switchingNature, 2001
- Mice deficient for the CD40 ligandImmunity, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993